Macrogenics Inc (NASDAQ: MGNX) kicked off on Friday, down -6.30% from the previous trading day, before settling in for the closing price of $3.81. Over the past 52 weeks, MGNX has traded in a range of $2.95-$21.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 15.77% over the last five years. While this was happening, its average annual earnings per share was recorded -729.52%. With a float of $58.05 million, this company’s outstanding shares have now reached $62.07 million.
The firm has a total of 339 workers. Let’s measure their productivity. In terms of profitability, gross margin is 92.34%, operating margin of -75.78%, and the pretax margin is -69.07%.
Macrogenics Inc (MGNX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Macrogenics Inc is 7.51%, while institutional ownership is 84.40%. The most recent insider transaction that took place on Apr 04 ’24, was worth 799,148. In this transaction Senior VP and General Counsel of this company sold 51,395 shares at a rate of $15.55, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 06 ’24, when Company’s Senior VP and General Counsel sold 19,625 for $21.50, making the entire transaction worth $421,938. This insider now owns 8,895 shares in total.
Macrogenics Inc (MGNX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.75 earnings per share (EPS), lower than consensus estimate (set at -0.17) by -0.58. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.79 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -729.52% per share during the next fiscal year.
Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators
Take a look at Macrogenics Inc’s (MGNX) current performance indicators. Last quarter, stock had a quick ratio of 3.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.57, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -2.22 in one year’s time.
Technical Analysis of Macrogenics Inc (MGNX)
Analysing the last 5-days average volume posted by the [Macrogenics Inc, MGNX], we can find that recorded value of 0.58 million was lower than the volume posted last year of 1.46 million. As of the previous 9 days, the stock’s Stochastic %D was 9.01%. Additionally, its Average True Range was 0.34.
During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 21.96%, which indicates a significant increase from 19.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.78% in the past 14 days, which was higher than the 87.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.67, while its 200-day Moving Average is $8.29. Now, the first resistance to watch is $3.76. This is followed by the second major resistance level at $3.96. The third major resistance level sits at $4.08. If the price goes on to break the first support level at $3.45, it is likely to go to the next support level at $3.33. Now, if the price goes above the second support level, the third support stands at $3.14.
Macrogenics Inc (NASDAQ: MGNX) Key Stats
The company with the Market Capitalisation of 209.96 million has total of 62,763K Shares Outstanding. Its annual sales at the moment are 58,750 K in contrast with the sum of -9,060 K annual income. Company’s last quarter sales were recorded 110,710 K and last quarter income was 56,310 K.
